Stock Report

Download full stock data and analysis for free Last Updated: 15-Oct-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Emmessar Biotech Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 524768

₹21.96

up-down-arrow ₹-0.15 (-0.68%)

As on 15-Oct-2026 13:05IST

Market cap

info icon

₹11 Cr

Revenue (TTM)

info icon

₹0 Cr

P/E Ratio

info icon

28

P/B Ratio

info icon

1.3

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -36.56 -36.56 -46.08 -27.35 -45.04
EBIT 4.33 -24.50 -44.89 -33.20 -218.06
Net Profit 282.35 -23.98 -2.00 2.78 -23.62
EPS 282.09 -23.98 -1.99 2.79 -23.62
Book Value -- -- 4.13 7.71 12.58
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-25Mar-24
EBIT-Margin info -153.49-143.89-454.01-171.48-212.21
Net Margin info 19.9019.5316.4812.0729.43
Return on equity info 7.5611.964.874.1910.66
Return on Capital info 13.0120.01--12.6311.42
Return on Assets info 6.269.514.183.488.89
Debt to Equity (x) info ----0.000.000.01

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
--
12.63
11.42
14.99
15.71
Peer Median
--
21.76
21.89
--
17.36
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

4.87

Lower than Peers by 10.59

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
4.87
4.19
10.66
7.85
8.01
Peer Median
15.45
17.93
16.42
--
17.35
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

4.18

Lower than Peers by 6.37

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
4.18
3.48
8.89
6.42
6.30
Peer Median
10.55
12.81
12.32
--
10.65
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-454.01

Lower than Peers by 471.66

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
-454.01
-171.48
-212.21
-76.78
-270.27
Peer Median
17.65
18.93
21.05
--
11.27
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

16.48

Higher than Peers by 2.53

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
16.48
12.07
29.43
18.19
20.82
Peer Median
13.95
14.94
15.51
--
11.45
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
0.00
67.74
152.59
58.61
155.58
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-46.08

Lower than Peers by 58.01

Year on year growth in net sales

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
-46.08
10.03
-45.53
179.31
-94.78
Peer Median
11.93
10.90
13.44
--
11.49
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-44.89

Lower than Peers by 66.85

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
-44.89
11.08
-50.57
20.66
-224.77
Peer Median
21.96
15.01
23.50
--
-1.10
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-2.00

Lower than Peers by 25.56

Year on year growth in profit after tax

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
-2.00
-57.82
48.79
5.97
-67.21
Peer Median
23.56
14.80
30.12
--
4.90
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-1.99

Lower than Peers by 21.67

Year on year growth in earnings per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
-1.99
-57.82
48.79
5.98
-67.21
Peer Median
19.69
14.27
29.02
--
10.00
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
--
4.13
11.07
8.03
8.21
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
--
--
0.01
0.01
--
Peer Median
0.01
0.06
0.03
--
0.18
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
--
--
0.01
0.01
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

20.28

Higher than Peers by 18.26

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
20.28
11.34
12.95
10.70
5.58
Peer Median
2.02
1.90
2.23
--
1.72
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

20.03

Higher than Peers by 18.54

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
20.03
11.16
12.78
10.46
5.51
Peer Median
1.49
1.46
1.59
--
1.41
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

127.75

Higher than Peers by 108.73

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
127.75
331.41
626.08
744.77
932.50
Peer Median
19.02
24.96
45.29
--
24.64
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

4.75

Lower than Peers by 16.42

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
4.75
2.91
4.02
1.06
3.54
Peer Median
21.16
21.77
20.10
--
23.77
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.04

Lower than Peers by 0.69

Sales / Average Total Assets

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
0.04
0.07
0.07
0.13
0.05
Peer Median
0.73
0.76
0.81
--
1.05
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
--
11.98
10.88
4.24
1,361.86
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
--
63.60
74.06
36.60
67.75
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
--
12.45
16.76
--
752.50
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
--
63.13
68.18
--
677.11
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

27.99

Lower than Peers by 3.48

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
27.99
48.02
19.81
24.59
28.90
Peer Median
31.47
26.81
39.85
--
26.65
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

1.33

Lower than Peers by 3.47

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
1.33
1.97
2.01
1.86
2.23
Peer Median
4.80
4.65
6.11
--
3.55
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
--
--
--
--
--
Peer Median
0.61
0.61
0.37
--
0.04
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

6.00

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
6.00
7.85
9.63
6.86
8.93
Peer Median
--
27.02
34.57
--
17.31
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

11

Lower than Peers by 17,753

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Emmessar Biotech
11
15
15
12
14
Peer Median
17,764
20,914
25,297
--
474
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...